Try our Advanced Search for more refined results
April 26, 2022
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al
Case Number:
1:22-cv-00035
Court:
Nature of Suit:
Judge:
District Judge John Preston Bailey
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 15, 2022
Judge Breathes 6 Months Of Life Into AstraZeneca Patent
A day after hearing arguments from Mylan lawyers that AstraZeneca should be bound to a January 2023 expiration date of a patent protecting the blockbuster asthma treatment Symbicort, a federal judge in West Virginia ruled Thursday that AstraZeneca deserved at least six months more of market exclusivity.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login